Disclosures for "Responsive Neurostimulation and Focal Cortical Dysplasia: Personalizing Technology to Pathology in Drug-Resistant Epilepsy"
-
Dr. Chang has nothing to disclose.
-
Author has nothing to disclose
-
The institution of Dr. Lundstrom has received research support from Medtronic. Dr. Lundstrom has a non-compensated relationship as a Consultant with Cadence Neuroscience that is relevant to AAN interests or activities.
-
Dr. Reeders has nothing to disclose.
-
Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precisis GmbH. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iVEAcare. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace, Inc.. Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rao has stock in Novela Neurotechnologies. Dr. Rao has stock in EnlitenAI. Dr. Rao has stock in Doximity, Inc. Dr. Rao has stock in Theta Neurotech. Dr. Rao has stock in Encephalogix.
-
Dr. Agashe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blackrock.